Ota K - Search Results

1

Pleuropulmonary Paragonimiasis with Multiple Nodules in the Pleura.

Ogata H, Harada E, Moriya S, Fukuyama S, Suzuki K, Shiraishi Y, Ando H, Uryu K, Shinozaki S, Ide M, Sakamoto A, Nakanishi T, Hamada N, Yoneshima Y, Ota K, Kohashi K, Tateishi Y, Miyashita Y, Oda Y, Matsumoto K. Ogata H, et al. Among authors: ota k. Intern Med. 2020 Aug 1;59(15):1879-1881. doi: 10.2169/internalmedicine.4457-20. Epub 2020 Apr 30. Intern Med. 2020. PMID: 32350198 Free PMC article.

2

Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.

Furuyama K, Harada T, Iwama E, Shiraishi Y, Okamura K, Ijichi K, Fujii A, Ota K, Wang S, Li H, Takayama K, Giaccone G, Nakanishi Y. Furuyama K, et al. Among authors: ota k. Cancer Sci. 2013 May;104(5):584-9. doi: 10.1111/cas.12125. Epub 2013 Mar 28. Cancer Sci. 2013. PMID: 23387505 Free PMC article.

3

Interleukin-22 attenuates double-stranded RNA-induced upregulation of PD-L1 in airway epithelial cells via a STAT3-dependent mechanism.

Seki N, Kan-O K, Matsumoto K, Fukuyama S, Hamano S, Tonai K, Ota K, Inoue H, Nakanishi Y. Seki N, et al. Among authors: ota k. Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):242-248. doi: 10.1016/j.bbrc.2017.10.045. Epub 2017 Oct 12. Biochem Biophys Res Commun. 2017. PMID: 29032197 Free article.

4

PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements.

Yoneshima Y, Ijichi K, Anai S, Ota K, Otsubo K, Iwama E, Tanaka K, Oda Y, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Among authors: ota k. Lung Cancer. 2018 Apr;118:36-40. doi: 10.1016/j.lungcan.2018.01.024. Epub 2018 Feb 2. Lung Cancer. 2018. PMID: 29572000

5

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade.

Tanaka K, Yanagihara T, Ikematsu Y, Inoue H, Ota K, Kashiwagi E, Suzuki K, Hamada N, Takeuchi A, Tatsugami K, Eto M, Ijichi K, Oda Y, Otsubo K, Yoneshima Y, Iwama E, Nakanishi Y, Okamoto I. Tanaka K, et al. Among authors: ota k. Oncotarget. 2018 Jul 17;9(55):30587-30593. doi: 10.18632/oncotarget.25743. eCollection 2018 Jul 17. Oncotarget. 2018. PMID: 30093971 Free PMC article.

6

Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti-PD-1 therapy.

Ikematsu Y, Tanaka K, Yanagihara T, Liu R, Inoue H, Yoneshima Y, Ota K, Iwama E, Takata S, Hata K, Takahata Y, Wataya H, Nakanishi Y, Okamoto I. Ikematsu Y, et al. Among authors: ota k. Lung Cancer. 2019 Dec;138:58-64. doi: 10.1016/j.lungcan.2019.10.011. Epub 2019 Oct 13. Lung Cancer. 2019. PMID: 31639551 Free article.

7

Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation.

Tsutsumi H, Yoneshima Y, Ota K, Otsubo K, Iwama E, Inoue H, Tanaka K, Nakanishi Y, Okamoto I. Tsutsumi H, et al. Among authors: ota k. Clin Lung Cancer. 2020 Jan;21(1):e21-e24. doi: 10.1016/j.cllc.2019.09.001. Epub 2019 Sep 26. Clin Lung Cancer. 2020. PMID: 31649000 No abstract available.

8

Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.

Furukawa R, Inoue H, Yoneshima Y, Tsutsumi H, Iwama E, Ikematsu Y, Ando N, Shiraishi Y, Ota K, Tanaka K, Nakanishi Y, Okamoto I. Furukawa R, et al. Among authors: ota k. Lung Cancer. 2021 May;155:144-150. doi: 10.1016/j.lungcan.2021.03.018. Epub 2021 Mar 26. Lung Cancer. 2021. PMID: 33819860 Free article.

9

Osimertinib-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone.

Takao T, Tanaka K, Shiraishi Y, Ota K, Yoneshima Y, Iwama E, Okamoto I. Takao T, et al. Among authors: ota k. Clin Lung Cancer. 2021 Sep;22(5):e784-e785. doi: 10.1016/j.cllc.2021.03.003. Epub 2021 Mar 16. Clin Lung Cancer. 2021. PMID: 33839042 No abstract available.

10

Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non-small cell lung cancer patients treated with osimertinib.

Liu R, Ota K, Iwama E, Yoneshima Y, Tanaka K, Inoue H, Tagawa T, Oda Y, Mori M, Nakanishi Y, Okamoto I. Liu R, et al. Among authors: ota k. Lung Cancer. 2021 Aug;158:156-161. doi: 10.1016/j.lungcan.2021.05.023. Epub 2021 May 25. Lung Cancer. 2021. PMID: 34059353 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,099 results

Search Page

Filters